eIF4E levels are rate-limiting for cancer development, as shown by the fact that in mice, a reduced dosage of eIF4E, while compatible with normal development and global protein synthesis, significantly impeded cellular transformation through its action on specific 5′UTRs [50]. The gene discussed is EIF4E; the disease is cancer.